CCLD — CareCloud, Inc.

CareCloud, Inc. (CCLD) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $31.3 million, up 13% from $27.6 million in Q1 2025.
• GAAP Operating Income: $1 million; GAAP Net Income: $922,000, down from $1.9 million year-over-year, impacted by increased amortization and integration costs from the Medsphere acquisition.
• Adjusted EBITDA: $5.4 million (17% of revenue), slightly down from $5.6 million in Q1 2025.
• Free Cash Flow: $2.4 million, down from $3.6 million in the prior year.
• Recurring Revenue: $23 million, an increase of approximately $5.3 million year-over-year.
• Adjusted Net Income: $2.2 million ($0.05 per share), compared to $2.3 million in Q1 2025.

2. Strategic Updates and Business Highlights

• Capital Structure Simplification: Closed a $50 million credit facility and announced the redemption of all outstanding Series B preferred stock, significantly simplifying the capital structure and reducing preferred dividends.
• AI Platform Development: The stratusAI Desk Agent is now commercially available, handling 75% of inbound calls for early adopters. The AI Center of Excellence is operational, driving AI integration across products.
• Acquisition Integration: The integration of Medsphere is progressing, expanding CareCloud's addressable market and enhancing product offerings across inpatient and outpatient services.
• Growth Strategy: Focus on cross-selling AI and revenue cycle management (RCM) services to both existing and newly acquired client bases.

3. Forward Guidance and Outlook

• 2026 Guidance: Revenue expected between $128 million and $132 million, adjusted EBITDA between $29 million and $31 million, and GAAP EPS between $0.20 and $0.23, representing over a 100% increase from 2025.
• Operational Efficiency: Anticipated margin improvements as integration costs decline and operational efficiencies from AI deployment materialize.

4. Bad News, Challenges, or Points of Concern

• Profitability Decline: GAAP net income decreased year-over-year due to integration costs and amortization related to acquisitions.
• Free Cash Flow Reduction: Decreased from $3.6 million in Q1 2025 to $2.4 million, primarily due to integration expenses.
• Seasonality: Q1 is typically a weaker quarter, which may affect profitability and revenue growth in the near term.
• Integration Risks: Ongoing integration of Medsphere could pose risks if not managed effectively, potentially impacting operational performance.

5. Notable Q&A Insights

• AI Product Development: Strong interest in new AI products, with a focus on successful implementation and expansion within existing clients.
• Series B Redemption Timing: Management emphasized the importance of removing the preferred equity overhang now due to improved cash flow and favorable credit market conditions.
• ATM Facility Use: The ATM equity facility will be used opportunistically for strategic acquisitions or to support growth objectives, but management maintains a conservative approach to equity issuance.
• Competitive Positioning: CareCloud's integrated AI solutions differentiate it from competitors who primarily offer point solutions, enhancing the value proposition for healthcare providers.

Overall, CareCloud reported solid revenue growth and made significant strides in simplifying its capital structure and advancing its AI strategy, despite facing challenges related to profitability and integration costs. The company remains optimistic about its growth trajectory for 2026.